SG11202113178QA - pH RESPONSIVE COMPOSITIONS AND USES THEREOF - Google Patents
pH RESPONSIVE COMPOSITIONS AND USES THEREOFInfo
- Publication number
- SG11202113178QA SG11202113178QA SG11202113178QA SG11202113178QA SG11202113178QA SG 11202113178Q A SG11202113178Q A SG 11202113178QA SG 11202113178Q A SG11202113178Q A SG 11202113178QA SG 11202113178Q A SG11202113178Q A SG 11202113178QA SG 11202113178Q A SG11202113178Q A SG 11202113178QA
- Authority
- SG
- Singapore
- Prior art keywords
- responsive compositions
- responsive
- compositions
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F293/00—Macromolecular compounds obtained by polymerisation on to a macromolecule having groups capable of inducing the formation of new polymer chains bound exclusively at one or both ends of the starting macromolecule
- C08F293/005—Macromolecular compounds obtained by polymerisation on to a macromolecule having groups capable of inducing the formation of new polymer chains bound exclusively at one or both ends of the starting macromolecule using free radical "living" or "controlled" polymerisation, e.g. using a complexing agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0032—Methine dyes, e.g. cyanine dyes
- A61K49/0034—Indocyanine green, i.e. ICG, cardiogreen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0054—Macromolecular compounds, i.e. oligomers, polymers, dendrimers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
- A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
- A61K49/0076—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form dispersion, suspension, e.g. particles in a liquid, colloid, emulsion
- A61K49/0082—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form dispersion, suspension, e.g. particles in a liquid, colloid, emulsion micelle, e.g. phospholipidic micelle and polymeric micelle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
- A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
- A61K49/0089—Particulate, powder, adsorbate, bead, sphere
- A61K49/0091—Microparticle, microcapsule, microbubble, microsphere, microbead, i.e. having a size or diameter higher or equal to 1 micrometer
- A61K49/0093—Nanoparticle, nanocapsule, nanobubble, nanosphere, nanobead, i.e. having a size or diameter smaller than 1 micrometer, e.g. polymeric nanoparticle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G81/00—Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers
- C08G81/02—Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers at least one of the polymers being obtained by reactions involving only carbon-to-carbon unsaturated bonds
- C08G81/024—Block or graft polymers containing sequences of polymers of C08C or C08F and of polymers of C08G
- C08G81/025—Block or graft polymers containing sequences of polymers of C08C or C08F and of polymers of C08G containing polyether sequences
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N31/00—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods
- G01N31/22—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods using chemical indicators
- G01N31/221—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods using chemical indicators for investigating pH value
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F2438/00—Living radical polymerisation
- C08F2438/01—Atom Transfer Radical Polymerization [ATRP] or reverse ATRP
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Inorganic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Dispersion Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nanotechnology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Graft Or Block Polymers (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962853593P | 2019-05-28 | 2019-05-28 | |
PCT/US2020/034783 WO2020243217A1 (en) | 2019-05-28 | 2020-05-28 | pH RESPONSIVE COMPOSITIONS AND USES THEREOF |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202113178QA true SG11202113178QA (en) | 2021-12-30 |
Family
ID=73554178
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202113178QA SG11202113178QA (en) | 2019-05-28 | 2020-05-28 | pH RESPONSIVE COMPOSITIONS AND USES THEREOF |
Country Status (11)
Country | Link |
---|---|
US (1) | US20220226511A1 (en) |
EP (1) | EP3976575A4 (en) |
JP (1) | JP2022534497A (en) |
KR (1) | KR20220015419A (en) |
CN (1) | CN114144399A (en) |
AU (1) | AU2020284544A1 (en) |
BR (1) | BR112021023940A2 (en) |
CA (1) | CA3142026A1 (en) |
IL (1) | IL288389A (en) |
SG (1) | SG11202113178QA (en) |
WO (1) | WO2020243217A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3159915A1 (en) * | 2019-11-04 | 2021-05-14 | Onconano Medicine, Inc. | Ph responsive block copolymer compositions, micelles, and methods of use |
CN115279422B (en) * | 2019-11-18 | 2024-03-29 | 昂科纳诺医药公司 | pH responsive compositions, formulations, and methods of imaging tumors |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009148121A1 (en) * | 2008-06-05 | 2009-12-10 | 株式会社 島津製作所 | Novel molecular assembly, molecular probe for molecular imaging and molecular probe for drug delivery system using the same, and molecular imaging system and drug delivery system |
EP2579027B1 (en) * | 2010-05-31 | 2019-07-03 | Eisai R&D Management Co., Ltd. | Fluorescent probe for imaging lymph nodes |
AU2015269068A1 (en) * | 2014-06-06 | 2016-12-22 | The Board Of Regents Of The University Of Texas System | Library of pH responsive polymers and nanoprobes thereof |
WO2019094906A1 (en) * | 2017-11-13 | 2019-05-16 | The Board Of Regents Of The University Of Texas System | Novel tfeb pathway agonists for metabolic diseases and ageing |
-
2020
- 2020-05-28 JP JP2021570290A patent/JP2022534497A/en active Pending
- 2020-05-28 AU AU2020284544A patent/AU2020284544A1/en active Pending
- 2020-05-28 BR BR112021023940A patent/BR112021023940A2/en unknown
- 2020-05-28 US US17/614,638 patent/US20220226511A1/en active Pending
- 2020-05-28 WO PCT/US2020/034783 patent/WO2020243217A1/en unknown
- 2020-05-28 KR KR1020217041890A patent/KR20220015419A/en unknown
- 2020-05-28 SG SG11202113178QA patent/SG11202113178QA/en unknown
- 2020-05-28 EP EP20814040.0A patent/EP3976575A4/en active Pending
- 2020-05-28 CA CA3142026A patent/CA3142026A1/en active Pending
- 2020-05-28 CN CN202080053111.2A patent/CN114144399A/en active Pending
-
2021
- 2021-11-25 IL IL288389A patent/IL288389A/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2020243217A1 (en) | 2020-12-03 |
EP3976575A4 (en) | 2023-08-16 |
EP3976575A1 (en) | 2022-04-06 |
CN114144399A (en) | 2022-03-04 |
CA3142026A1 (en) | 2020-12-03 |
AU2020284544A1 (en) | 2021-12-23 |
KR20220015419A (en) | 2022-02-08 |
BR112021023940A2 (en) | 2022-02-15 |
IL288389A (en) | 2022-01-01 |
JP2022534497A (en) | 2022-08-01 |
US20220226511A1 (en) | 2022-07-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL279897A (en) | Fusosome compositions and uses thereof | |
SG11202011015QA (en) | Fusosome compositions and uses thereof | |
IL284878A (en) | Trem compositions and uses thereof | |
IL279755A (en) | Senolytic compositions and uses thereof | |
GB201916248D0 (en) | Compositions and methods and uses relating thereto | |
IL288389A (en) | Ph responsive compositions and uses thereof | |
GB201905386D0 (en) | Probiotic compositions and uses thereof | |
IL277663A (en) | Erenumab compositions and uses thereof | |
GB201909298D0 (en) | Novel compositions and uses thereof | |
GB201807576D0 (en) | Compositions and uses thereof | |
GB201712592D0 (en) | Novel compositions and uses thereof | |
IL285916A (en) | Novel compositions and use thereof | |
GB201821138D0 (en) | Compositions and uses thereof | |
GB201812334D0 (en) | Compositions and uses thereof | |
GB201907351D0 (en) | Compositions and uses thereof | |
GB201905690D0 (en) | Compositions and uses thereof | |
GB201905593D0 (en) | Compositions and uses thereof | |
GB201904289D0 (en) | Compositions and uses thereof | |
GB201904281D0 (en) | Compositions and uses thereof | |
GB201902752D0 (en) | Compositions and uses thereof | |
GB201902750D0 (en) | Compositions and uses thereof | |
GB201902753D0 (en) | Compositions and uses thereof | |
GB201902758D0 (en) | Compositions and uses thereof | |
GB201902759D0 (en) | Compositions and uses thereof | |
GB201821144D0 (en) | Compositions and uses thereof |